Literature DB >> 9232418

Defective T-cell receptor gamma gene rearrangement in interleukin-7 receptor knockout mice.

S Candéias1, J J Peschon, K Muegge, S K Durum.   

Abstract

T-cell receptor (TCR) genes need to be rearranged by a site specific-VDJ recombinase before they are expressed. This process, initiated in CD44+25+ thymocytes, takes place during the early stage of T-cell differentiation in the thymus. Interleukin-7 receptor alpha chain knockout (IL-7R-/-) mice are severely deficient in B-lymphocytes and alpha beta T-cells and completely lack the gamma delta T-cell lineage. Thymocyte development is arrested at a very early stage (DN CD44+CD25-). Because this arrest is earlier than in mice with a block in VDJ recombination, we examined the rearrangement status of TCR genes in thymocytes from IL-7R-/- mice. The TCR beta locus showed a nearly normal pattern of VDJ rearrangements, consistent with the presence of alpha beta T-cells in these mice. However, TCR gamma locus rearrangement was absent or severely reduced for all the V gamma genes analyzed (V gamma 3, V gamma 4, V gamma 1.1, V gamma 1.2 and V gamma 2). In contrast, the delta locus showed little reduction in rearrangement. The defect in gamma rearrangements in IL-7R-/- thymocytes is not simply due to an absence of mature gamma delta T-cells, since TCR delta-/- mice, which also have only alpha beta T-cells, had normal levels of gamma and delta rearrangements. These findings indicate that one or both of the two known ligands of IL-7R, IL-7 and thymic stromal lymphopoietin (TSLP) serves as an extrinsic signal to specifically rearrange the TCR gamma locus.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9232418     DOI: 10.1016/s0165-2478(97)00062-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

Review 1.  Targeting the Jak/STAT pathway for immunosuppression.

Authors:  J J O'shea
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

2.  Stat5a/b are essential for normal lymphoid development and differentiation.

Authors:  Zhengju Yao; Yongzhi Cui; Wendy T Watford; Jay H Bream; Kunihiro Yamaoka; Bruce D Hissong; Denise Li; Scott K Durum; Qiong Jiang; Avinash Bhandoola; Lothar Hennighausen; John J O'Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

Review 3.  Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia.

Authors:  Noa Tal; Chen Shochat; Ifat Geron; Dani Bercovich; Shai Izraeli
Journal:  Cell Mol Life Sci       Date:  2013-04-27       Impact factor: 9.261

Review 4.  Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.

Authors:  C M Capitini; A A Chisti; C L Mackall
Journal:  J Intern Med       Date:  2009-08       Impact factor: 8.989

5.  The interleukin 7 receptor is required for T cell receptor gamma locus accessibility to the V(D)J recombinase.

Authors:  M S Schlissel; S D Durum; K Muegge
Journal:  J Exp Med       Date:  2000-03-20       Impact factor: 14.307

6.  Enterocyte expression of interleukin 7 induces development of gammadelta T cells and Peyer's patches.

Authors:  K Laky; L Lefrançois; E G Lingenheld; H Ishikawa; J M Lewis; S Olson; K Suzuki; R E Tigelaar; L Puddington
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

7.  Interleukin-7 receptor signaling is crucial for enhancer-dependent TCRδ germline transcription mediated through STAT5 recruitment.

Authors:  Alonso Rodríguez-Caparrós; Shizue Tani-Ichi; Áurea Casal; Jennifer López-Ros; Carlos Suñé; Koichi Ikuta; Cristina Hernández-Munain
Journal:  Front Immunol       Date:  2022-08-19       Impact factor: 8.786

8.  Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility.

Authors:  S K Durum; S Candèias; H Nakajima; W J Leonard; A M Baird; L J Berg; K Muegge
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

9.  Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation.

Authors:  Atar Lev; Amos J Simon; Ortal Barel; Eran Eyal; Efrat Glick-Saar; Omri Nayshool; Ohad Birk; Tali Stauber; Amit Hochberg; Arnon Broides; Shlomo Almashanu; Ayal Hendel; Yu Nee Lee; Raz Somech
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.